Somewhat Positive Press Coverage Somewhat Unlikely to Affect Owens & Minor (NYSE:OMI) Share Price

Press coverage about Owens & Minor (NYSE:OMI) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Owens & Minor earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.2052855805491 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Shares of Owens & Minor (OMI) traded up $0.13 during trading on Monday, reaching $15.70. 1,832,090 shares of the company’s stock traded hands, compared to its average volume of 1,514,865. Owens & Minor has a 52 week low of $15.01 and a 52 week high of $36.73. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.77 and a quick ratio of 0.95. The stock has a market cap of $953.66, a P/E ratio of 12.16, a P/E/G ratio of 1.47 and a beta of 0.92.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.26 per share. This is an increase from Owens & Minor’s previous quarterly dividend of $0.26. This represents a $1.04 annualized dividend and a yield of 6.62%. The ex-dividend date of this dividend is Wednesday, March 14th. Owens & Minor’s dividend payout ratio (DPR) is presently 80.47%.

OMI has been the subject of several analyst reports. Leerink Swann reissued a “market perform” rating and issued a $23.00 price target (down previously from $34.00) on shares of Owens & Minor in a research note on Thursday, November 2nd. Zacks Investment Research raised shares of Owens & Minor from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Credit Suisse Group reaffirmed an “underperform” rating and set a $17.00 price objective (down previously from $31.00) on shares of Owens & Minor in a research report on Monday, November 20th. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $22.00 target price on shares of Owens & Minor in a report on Tuesday, December 19th. Finally, ValuEngine lowered shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Five analysts have rated the stock with a sell rating and four have given a hold rating to the stock. The stock presently has an average rating of “Sell” and an average price target of $26.50.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Insider Buying and Selling by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with's FREE daily email newsletter.

Leave a Reply